Meisner Lara (CIK 0001883986)

Latest company ownership

Role: Chief Legal Officer
Shares held
33,807
Last filed at
Oct 1, 2025
Confidence Score
38.3
2025Q4
Confidence Score History
2025Q1 2025Q4
Role: Chief Legal Officer
Shares held
28
Last filed at
Jun 20, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 29, 2025 Oct 1, 2025 Bicara Therapeutics Inc. Chief Legal Officer Sell 7.5 -33,807 -100.00% $498.7K
Sep 15, 2025 Sep 17, 2025 Bicara Therapeutics Inc. Chief Legal Officer Sell 10.0 -15,829 -100.00% $181.9K
Jun 16, 2025 Jun 18, 2025 Bicara Therapeutics Inc. Chief Legal Officer Sell 10.0 -15,829 -100.00% $165.1K
Mar 14, 2025 Mar 18, 2025 Bicara Therapeutics Inc. Chief Legal Officer Sell 5.0 -79,146 -100.00% $1M
Jun 15, 2023 Jun 20, 2023 Viridian Therapeutics, Inc.\DE Chief Legal Officer Sell 37.5 -2,296 -3.69% $64.3K
Jun 2, 2023 Jun 6, 2023 Viridian Therapeutics, Inc.\DE Chief Legal Officer Sell 28.8 -7,500 -7.70% $186.1K
Mar 9, 2023 Mar 10, 2023 Viridian Therapeutics, Inc.\DE General Counsel and Secretary Sell 7.5 -29,971 -100.00% $871.3K
Jan 23, 2023 Jan 25, 2023 Viridian Therapeutics, Inc.\DE General Counsel and Secretary Sell 10.0 -6,843 -100.00% $244K
Dec 20, 2022 Dec 22, 2022 Viridian Therapeutics, Inc.\DE General Counsel and Secretary Sell 7.5 -16,926 -100.00% $493.4K
Dec 15, 2022 Dec 19, 2022 Viridian Therapeutics, Inc.\DE General Counsel and Secretary Sell 13.8 -1,597 -100.00% $45.3K
Dec 12, 2022 Dec 14, 2022 Viridian Therapeutics, Inc.\DE General Counsel and Secretary Sell 7.5 -16,256 -100.00% $457.1K
Nov 15, 2022 Nov 16, 2022 Viridian Therapeutics, Inc.\DE General Counsel and Secretary Sell 10.0 -8,125 -100.00% $179.2K